HealthPsyc6 Flashcards

1
Q

Case study, Lucy:

Diagnosed 2 days ago with breast cancer

A

Aged 37; married with one child (3 years old); would like another child
Decisions to make
• Surgery
• ‘Mastectomy’ versus ‘Lumpectomy + Radiotherapy’?
• Breast reconstruction?
• Immediate or delayed or not at all?
• More (adjuvant) “insurance” treatment?
• Chemotherapy?
• Hormone therapy?
• Fertility options?
• Fertility treatment prior to chemotherapy?
• Other decisions: Complementary therapy; Clinical trial

• Weighing up medical and personal concerns

My health /the benefits in terms of survival
& My ability to keep the family functioning/quality of life

  • Effects of treatment on ability to have children, sexuality or body image
  • Weighing up uncertain risks against uncertain side-effects (additional chemotherapy / hormone therapy)

20% risk/chance of relapse
(Likely) loss of fertility / onset of menopausal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Paternalism

A
(Professional-centred approach)
• Doctor is the Expert
• Protects patient from disturbing
information
• Takes away the burden of
decision-making
• Projects confidence and care
• Dr makes the decision in patient’s best interests
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Patient-directed/Autonomous:

Patient as “the consumer”

A

Doctor
• Tells patient all the relevant information
• Is available to answer patient’s questions
• Does not make a recommendation
• Allows patient to reach his/her own decision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Shared decision-making (SDM)

A

• The SDM approach is positioned in
between the paternalistic and patientdirected
approaches
• A process in which the health professional
and the patient collaborate in making the
best use of evidence to make informed,
value-based decisions that they can both
agree upon
• Central tenet of SDM is that patients and
health professionals have different but
equally valuable perspectives and roles
within the medical encounter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Legislation and policy

A

• “Health programs should facilitate collaborative processes between patients, caregivers, and clinicians that engage the patient and caregiver in decision-making”. (US; 2010)
•“No decisions about me, without me” (UK, 2012)
• “Patients have a right to be included in decisions and choices about [their] care” (Australian Healthcare Charter of Healthcare Rights;
Australian Commission on Safety and Quality in Healthcare, 2008)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SDM Clinicians Expertise

A
Diagnosis 
Disease aetiology 
Prognosis 
Treatment options
Outcome probabilities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SDM Patients Expertise

A
Experience of illness
Social circumstances
Attitude to risk
 Values
Preferences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SDM Approaches

A
  • Many different approaches/models of SDM
  • Charles et al (1997; 1999)
  • Legare et al. (2011)
  • Elwyn et al. (2012)
  • No one accepted “gold standard” definition of SDM
  • Approaches often similar in their essence, but have different names, stages, focus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SDM Approach: Charles et al. (1997; 1999)

A

SDM Framework by Charles, Gafni & Whelan (1997, 1999)
• Pioneering model of SDM
• Most widely cited model of SDM (2040 citations)
• An encounter in which BOTH health professional and patient:

  • Share information (Information exchange): physician informs the patient of all relevant information about available treatment options (e.g. risks/benefits); patient provides information about their preferences, values, beliefs, social context, and knowledge about the illness/treatment.
  • Mutually deliberate on treatment options (Deliberation): process of expressing and discussing treatment preferences in an interactive process.
  • Choose a treatment to implement (Decision): both parties work towards reaching an agreement and action plan to follow.

See slides for some good diagrams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SDM Approach: Legare et al. (2011)

A

Legare et al. (2011) Interprofessional Model of SDM
• Extends upon the pioneering models of SDM
• Adds additional health professionals to SDM model
• Acknowledges the significant roles of family and decision coaches
• Includes additional stages of DM
• Decision to be made
• Feasibility
• Implementation
• Outcomes

See slides again

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

SDM Approach: Elwyn et al. (2012)

A

Shared decision making: a model for clinical practice.
• Extends upon the “pioneering” SDM models
• Provides guidance about how to accomplish approach in routine clinical practice

  • 3-step model: practical, easy to remember
  • Based on
  • Choice Talk (introducing choice)
  • Option Talk (describing options, decision-support tools)
  • Decision Talk (helping patients explore preferences and make decisions)
  • Underpinned by process of deliberation

Shared decision making: a model for clinical practice.
• Acknowledges that DM may be an ongoing and progressive process and may be repeated over time
• Acknowledges that the SDM process begins early, well before the patient has informed preferences
• Choice talk: does not necessarily have to occur during a face-to-face consultation (email, letter, telephone call)
• Option talk: May include use of decision support (e.g. decision aids, option grids) and discussions with others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should SDM be used

A
  • One size does not fit all
  • Patient preferences vary
  • BUT… Particularly appropriate in preference-sensitive scenarios:
  • Treatment outcomes are uncertain
  • Quality of life may be affected
  • Patient values determine the best outcome
  • For example:
  • Mastectomy vs lumpectomy + radiotherapy
  • Adjuvant chemotherapy where benefit is small
  • Cancer prevention interventions (e.g. tamoxifen)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Do patients want SDM?

A
  • Australian survey (Davey et al, 2002): >90% of women preferred SDM re screening and diagnostic tests
  • European survey (Coulter & Jenkinson, 2005; n>8,000): >70% of patients wanted SDM
  • Should not be forced on patients- DM style should align with patient’s preferences
  • Discrepancies between preferred and actual decision-making roles may lead to:
  • Decreased patient satisfaction with care
  • Decreased quality of life (Singh et al., 2010)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is SDM Effective?

A
  • Patients involved in SDM report increased:
  • Overall satisfaction with their care
  • Satisfaction with the doctor-patient relationship
  • Satisfaction with the decision-making process
  • Knowledge
  • Quality of life
  • Treatment adherence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SDM Patient Barriers

A

Conforming to social expectations of doctor/patient
roles
• Emotionally vulnerable and emotional, possibly feeling
powerless
• Lack a medical vocabulary

There is great variability in the degree to which patients prefer to be involved in decision-making
Empowerment vs. Abandonment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SDM Doctor Barriers

A
  • Not an easy task for the health professional
  • Most not trained in SDM (particularly in Australia!)
Common misconceptions/myths:
• “Patients will feel unsupported when making decisions”
• “It will lead to longer consultations”
• “I already do this”
• “It will make people more anxious”
• “Not everyone can do this”
• “There is no evidence behind SDM”
• “SDM is too complex for some vulnerable patients (e.g. low health literacy)
- they won’t understand” 
(Hoffman et al, 2014 – see reading)
17
Q

Communication strategies/interventions for patients

A
  • Coaching patients to ask questions (ASK)
  • Decision Aids (DAs)
  • Question-Prompt Lists (QPLs)
  • Clinician strategies/interventions also exist (e.g. communication skills training)
18
Q

Asking questions can help

A

• Study in a GP setting: standardised patients (actors)
• Patients (actors) coached to ask 3 questions:
1. What are my options?
2. What are the possible benefits and harms of those options?
3. How likely are the benefits and harms of each option to occur?
• Designed to prompt physicians to provide minimum information that
patients need to make an informed decision
• It worked! In consultations where patient-actors asked questions:
• doctors gave more information
• patients were more likely to share in decision-making
(Shepherd et al, PEC, 2011)

19
Q

ASK Feasibility Study

A

4-min ASK video clip viewed by 121 participants:
• https://www.youtube.com/watch?v=vVnTw9ldX8I
• For those participants making a decision:
• 87% asked at least 1/3 questions and 43% asked all 3 questions
• 49% recalled all 3 questions two weeks post-consultation

20
Q

Decision aids (DAs)

A
  • Inform
  • Provide evidence-based information about: the condition, ALL options, benefits and harms
  • Communicate probabilities in a clear graphical form
  • Clarify values
  • Explore patient experiences
  • Ask which benefits/harms matters most
  • Facilitate communication
  • Support process
  • Guide in steps in deliberation/communication
  • Provide worksheets, list of questions

• A surge in production of DAs
• The optimal format will depend on the clinical situation,
the patient population involved and any cost restrictions
• More detailed DAs seem more effective than simple DAs

  • The International Patient Decision Aid Standards (IPDAS) – 2006
  • road criteria to determine the quality of patient DAs
  • DA inventories:
  • the Ottawa Hospital Research Institute A to Z Inventory of DAs
  • http://decisionaid.ohri.ca/index.html
21
Q

How do DAs benefit patients

A
  • Improve knowledge of screening/treatment options
  • Facilitate more realistic and accurate expectations of possible benefits and harms
  • Facilitate choices that are more consistent with patients’ values/what matters to them most
  • Increase active participation in decision-making
  • Improve doctor-patient communication
  • Reduce overuse of major elective surgeries, PSA (prostate cancer) screening, and the choice to use menopausal hormones (HRT)
22
Q

Question prompt lists (QPLs)

A

• “I just don’t know where to start- can I ask
questions? What questions do I ask?”
• Provide a list of common questions patients may
want to ask
• Questions may relate to:
• My illness – what is it (diagnosis)
• How serious is my illness (prognosis)
• Treatment options
• Benefits of treatments
• Costs of treatments
• Support for me and my family
• Invite patient to tick relevant questions, add
their own
• Are taken into consultation as a prompt
• Endorse question asking
• Both patients and doctors find QPL useful and helpful
• Increases likelihood of asking “difficult” questions
• More effective with Dr’s endorsement
• Can be used in subsequent consultations
• http://www.cancerinstitute.org.au/patient-support/what-i-need-to-ask

23
Q

Family involvement in DM

A
  • Very little research on family involvement in DM
  • However, family usually involved in some capacity
  • Hobbs et al. (2015), US, N=5285 cancer patients
  • Family controlled decision-making: 1.5%
  • Shared decision-making with family: 49.4%
  • Some family input: 22.1%
  • Little family input: 28.5%
  • Patients more likely to prefer greater family involvement if they were: married, female, older, from an ethnically diverse background (Asian, Hispanic)
24
Q

How do family fit into the DM process

A
  • Based on qualitative interviews, quantitative analysis of consultation audiotapes (Laidsaar-Powell et al., 2015; 2016;)
  • Family involvement can extend across all stages of DM (and more)
  • Involvement usually extends to: before, during, after consultation
  • Additional stages to those proposed by Charles et al. (1997; 1999)
25
Q

Decision making stages involving family

A

Pre consultation preparation
• Some FMs influenced which physician or hospital to attend
• Some FMs did research, pre-empted the treatment options, and discussed this with patient, other family, friends

Information exchange
• Inside consultation: family may listen to/provide information, take notes, ask questions, translate/simplify information for patient
• Outside consultation: family may recall and discuss consultation information with patient/others, research treatment options

Deliberation
• Spectrum- Supportive» sounding board» actively involved&raquo_space; dominant
• In-consultation: family may support patient preferences, express own preferences
• Outside-consultation: patient-family may continue discussions- usually an ongoing, iterative, informal series of discussions about feelings between patient-FMs

26
Q

Decision and Post Decision Family Stages

A

Decision
• Four overarching types of family influence over decisions

No family influence: Physician and/or patient controlled

Family influence through supportive actions

‘Shared’ patient and family influence

Controlling family influence

  • Mostly family were either involved in “supportive” or “shared” capacity
  • Mostly family involved in process but patient made the final decision

Post decision reflection
• A small number of patients and FMs reported continued discussions about decision after decision was made
• Discussed whether it was the ‘right’ decision, and whether they should change their minds

27
Q

Attitudes towards family involvement in DM process: Patient as priority

A
  • Most participants believed patient should have ultimate authority over decision- “It’s their body!”
  • Many HPs stated patient wishes should be paramount
  • Guided by laws protecting patient confidentiality and autonomy
  • Family who compromise patient autonomy (e.g. conflicting treatment wishes, requests for non-disclosure) identified as a challenge by HPs
28
Q

Attitudes towards family involvement in DM process: Rights of the family to be involved

A
  • While emphasising patient rights, many also acknowledged that family deserve involvement in DM
  • Acknowledged cancer and its treatment also affects the family emotionally and practically
  • Some HPs appeared to have internal struggle between patient and family rights
  • Some situations may call for greater family involvement- end of life, decisions affecting fertility or sexuality, treatments where family has to help
29
Q

Attitudes towards family involvement in DM process: Balancing patient priority with family needs

A
  • Family “influence” not necessarily a bad thing. Might be really appropriate or needed in certain situations- need to be flexible based on patient (and family) needs
  • Family involvement does not necessarily mean family dominance
  • Many FMs saw their own role as being ‘backup’ or ‘auxilliary’ to the patient, and self-censored their own opinions
  • Many benefits of family involvement in DM process- feeling more informed, thinking more about decision, improved confidence about decision, feeling supported, shared burden